CEVI.ST

🇸🇪 SE

CellaVision AB (publ)

Healthcare

Price

169.80 SEK

Market cap

$4.05B

Current yield

1.6%

Avg yield

0.8%

P/E

31.4

Net debt / EBITDA

-0.64

5Y EPS growth

9.0%

1Y return

-7.8%

Score breakdown

Current yield

Current dividend yield must be at least 8% to match the Börsdata screen.

1.6%

≥ 8%

Avg yield

Long-term average yield (5-year proxy) must also be at least 8%.

0.8%

≥ 8%

Net debt / EBITDA

Net debt below 2x EBITDA keeps leverage from eating the dividend.

-0.64

< 2

Return metric

ROE ≥ 15% signals the business earns well on equity. Falls back to ROI, ROIC or ROA when ROE is unavailable.

15.1% (ROE)

≥ 15%

P/E ratio

P/E below 15 aims to avoid overpaying for the income stream.

31.4

< 15

5Y EPS growth

5-year EPS growth ≥ 10% suggests the dividend has some underlying growth support.

9.0%

≥ 10%

1Y performance

1-year performance ≥ 0% filters out stocks in severe near-term downtrends.

-7.8%

≥ 0%

Total score28

Dividend history

Current yield (last 12 months paid): 1.6%. Bars show each calendar year; the latest bar is year-to-date.

20171.0%(1.500 SEK)

20180.6%(1.500 SEK)

20190.4%(1.500 SEK)

20210.2%(0.750 SEK)

20220.8%(2.000 SEK)

20231.1%(2.250 SEK)

20241.0%(2.250 SEK)

20251.7%(2.500 SEK)

2026 YTD1.7%(2.750 SEK)

Return metric shown: 15.1% (ROE). Yahoo does not always provide ROE; ROI, ROIC or ROA is used as a fallback.